longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

002038

002038
----

LongbridgeAI

SL PHARM: Expected net profit in the first half of the year to increase by 237.95%-356.24% year-on-year

Zhitong
Jul 11, 2025 at 10:58 AM

SL PHARM announced that it expects a net profit of 100 million to 135 million yuan in the first half of 2025, an increase of 237.95% to 356.24% compared to 29.59 million yuan in the same period last year

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

SL PHARM

SL PHARM

002038.SZ

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--